US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Abbott Laboratories (NY:ABT)

97.50 +0.81 (+0.84%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >
News headline image
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? ↗
Via MarketBeat
News headline image
How to Pick a Healthcare Stock That Can Weather Any Market ↗
How does a nearly 3% (and growing) dividend yield sound? 
Via The Motley Fool
Topics Economy World Trade
News headline image
This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio
Abbott Labs is a balance of income and growth. 
Via Barchart.com
News headline image
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom ↗
They offer investors very different value propositions. 
Via The Motley Fool
ABBOTT LABORATORIES (NYSE:ABT) Posts Mixed Q1 2026 Results, Cuts Guidance After Exact Sciences Acquisition ↗
Via Chartmill
News headline image
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount ↗
Various concerns weighed on appetite for stocks in recent weeks. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond ↗
These stocks pay juicy dividends but also offer much more. 
Via The Motley Fool
Topics Economy
News headline image
Abbott Stock Crash: Rebound Could Be Coming Fast ↗
Via MarketBeat
News headline image
Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings ↗
Abbott Laboratories (NYSE:ABT) reported upbeat Q1 earnings but lowered its 2026 outlook, including dilution from Exact Sciences acquisition. 
Via Benzinga
TSMC's Chip Heat Extends the Record Run, Then Netflix Drops a Double Surprise After the Bell ↗
Via Chartmill
News headline image
Why Abbott Laboratories Stock Tumbled on Thursday ↗
It essentially met analyst expectations for its inaugural quarter of 2026. 
Via The Motley Fool
Which S&P500 stocks are moving on Thursday? ↗
Via Chartmill
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns. 
Via The Motley Fool
Topics Economy
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Abbott (ABT) Q1 2026 Earnings Call Transcript ↗
Abbott (ABT) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
Abbott Laboratories’s (NYSE:ABT) Q1 CY2026 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) announced better-than-expected revenue in Q1 CY2026, with sales up 7.8% year on year to ... 
Via StockStory
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q1 Earnings ↗
Abbott Laboratories (NYSE: ABT) to report Q1 earnings on April 16, expected EPS of $1.15 and revenue of $11B. Acquired Exact Sciences, stock up 0.4%. 
Via Benzinga
News headline image
Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks
As the sun sets on the era of easy profits from elevated interest rates, the titans of Wall Street are preparing to unveil a new chapter in their growth stories. For the first time in three years, the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Era of the Megadeal: Inside the $438 Billion Surge Reshaping Corporate America
The first quarter of 2026 has concluded with a historic roar, as global Mergers and Acquisitions (M&A) reached a staggering $438 billion in deal value. This surge, a 155% increase over the same period... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
The global financial landscape underwent a seismic shift in the first quarter of 2026, as a "perfect storm" of stabilizing interest rates and technological urgency triggered a historic wave of mergers... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
This Pharma Dividend Has Been Raised Every Single Year for Over a Decade ↗
Spun off from a Dividend King in 2013, this pharmaceutical stock is a rising star among dividend growth stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain? ↗
In the world of investing, stability is a prized commodity. Few companies embody that stability better than Abbott Laboratories (NYSE: ABT), a diversified healthcare powerhouse and a member of the... 
Via MarketBeat
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a... 
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
The Decacorn of Performance: Whoop Secures $10.1 Billion Valuation in Landmark Series G Led by TPG
In a move that cements the "human performance" category as a pillar of the future economy, Whoop has officially closed a massive $575 million Series G funding round, catapulting the wearable technology... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
ST. LOUIS — April 6, 2026 — Stereotaxis (NYSE: STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias and other endovascular procedures, announced today that... 
Via MarketMinute
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
Via Finterra
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
58 59 Next >